Synthesis and evaluation of 1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7-(4-(2-(4-substitutedpiperazin-1-yl)acetyl)piperazin-1-yl)quinoline-3-carboxylic acid derivatives as anti-tubercular and antibacterial agents.

doi:10.1016/j.ejmech.2013.10.055

Paper

DOI: 10.1016/j.ejmech.2013.10.055

Synthesis and evaluation of 1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7-(4-(2-(4-substitutedpiperazin-1-yl)acetyl)piperazin-1-yl)quinoline-3-carboxylic acid derivatives as anti-tubercular and antibacterial agents.

Published Jan 7, 2014 · Narva Suresh, H. N. Nagesh, J. Renuka

European journal of medicinal chemistry

Q2 SJR score

Citations

Influential Citations

Full textSemantic Scholar

Abstract

Abstract hidden due to publisher request; this does not indicate any issues with the research. Click the full text link above to read the abstract and view the original source.

In Vitro Study

Study Snapshot

Novel 1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7-(4-(2-(4-substitutedpiperazin-1-yl)acetyl)piperazin-1-yl)quinoline-3-carboxylic acid

PopulationOlder adults (50-71 years)

Sample size24

MethodsObservational

OutcomesBody Mass Index projections

ResultsSocial networks mitigate obesity in older groups.

Sign up to use Study Snapshot

Consensus is limited without an account. Create an account or sign in to get more searches and use the Study Snapshot.

Create an account

Full text analysis coming soon...

References

DOI: 10.1002/med.21262

Antituberculosis Drug Research: A Critical Overview

New antitubercular compounds like moxifloxacin, PA824, and TMC207 show promising potential, but some show cross-resistance to currently used drugs.

2013·118citations·Beena et al.·Medicinal Research Reviews

Medicinal Research Reviews

DOI: 10.1016/j.ejmech.2013.03.027

Anti-tubercular agents. Part 7: a new class of diarylpyrrole-oxazolidinone conjugates as antimycobacterial agents.

Diarylpyrrole-oxazolidinone conjugates show potent anti-tubercular activity against Mycobacterium tuberculosis H37 Rv and drug resistance strains, with compound 4i being the most potent.

2013·20citations·A. Kamal et al.·European journal of medicinal chemistry

European journal of medicinal chemistry

DOI: 10.1016/j.ejmech.2012.11.040

Synthesis and in vitro activity of 1,2,4-triazole-ciprofloxacin hybrids against drug-susceptible and drug-resistant bacteria.

Novel 1,2,4-triazole-ciprofloxacin hybrids show higher antibacterial activity than ciprofloxacin, both against drug-susceptible and drug-resistant bacteria.

2013·86citations·T. Plech et al.·European journal of medicinal chemistry

European journal of medicinal chemistry

DOI: 10.1016/j.ejmech.2011.10.014

Synthesis of lipophilic dimeric C-7/C-7-linked ciprofloxacin and C-6/C-6-linked levofloxacin derivatives. Versatile in vitro biological evaluations of monomeric and dimeric fluoroquinolone derivatives as potential antitumor, antibacterial or antimycobacterial agents.

Lipophilic dimeric C-7/C-7-linked ciprofloxacin and C-6/C-6-linked levofloxacin derivatives show potential as antitumor, antibacterial, and antimycobacterial agents.

2011·44citations·J. Azéma et al.·European journal of medicinal chemistry

European journal of medicinal chemistry

DOI: 10.1016/j.ejmech.2011.06.032

Synthesis and in vitro antibacterial activity of a series of novel gatifloxacin derivatives.

Novel gatifloxacin derivatives show good antibacterial activity against Staphylococcus aureus, MRSA, and MRSE, with compound 20 being 2–32-folds more potent than levofloxacin and parent GTFX against Pseudomonas aer

2011·39citations·Yun Chai et al.·European journal of medicinal chemistry

European journal of medicinal chemistry

Citations

DOI: 10.1039/d4ra01332h

Synthesis of ciprofloxacin-linked 1,2,3-triazole conjugates as potent antibacterial agents using click chemistry: exploring their function as DNA gyrase inhibitors via in silico- and in vitro-based studies

Ciprofloxacin-linked 1,2,3-triazole conjugates show excellent antibacterial activity and low toxicity, with compound 10b being the most potent DNA gyrase inhibitor compared to ciprofloxacin.

2024·0citations·Upendra Kumar Patel et al.·RSC Advances

RSC Advances

DOI: 10.1002/slct.202303083

Synthesis and Biological Evaluation of Diphenyl Ether‐Linked Quinolone Derivatives as Antibacterial Agents

Diphenyl ether-linked fluoroquinolone derivatives show potent inhibitory activity against staphylococcus aureus and mycobacteria, with potential for developing new antibacterial agents against drug-resistant bacteria.

2023·1citation·S. M. Ghouse et al.·ChemistrySelect

ChemistrySelect

DOI: 10.1016/j.bmcl.2023.129378

Anticancer evaluation of benzofuran derivatives linked to dipiperazine moiety.

Benzofuran derivatives linked to dipiperazine moiety show potent antitumor activity, with compounds 8c and 8d showing better results against A549, and compound 8d inducing cell apoptosis.

2023·1citation·Yixin Liu et al.·Bioorganic & medicinal chemistry letters

Bioorganic & medicinal chemistry letters

DOI: 10.1080/00397911.2022.2119415

Synthesis, reaction, antimicrobial, and docking study of new chalcones incorporating isoquinoline moiety

Chalcone 6Aa, incorporating isoquinoline moiety, shows the lowest MIC values against sensitive bacteria E. coli and the highest binding affinity towards thymidine phosphorylase enzyme.

2022·3citations·S. Mukhtar et al.·Synthetic Communications

Synthetic Communications

DOI: 10.1080/10406638.2021.2019065

Reactivity of N-(4-Nitrophenyl)propionohydrazonoyl Bromide. Synthesis and Antimicrobial Study of Thiadiazoles and 4,6-Dithia-1,2,9-triazaspiro-[4.4]-non-2-en-8-ones

Thiadiazoles and 4,6-dithia-1,2,9-triazaspiro[4.4]-non-2-en-8-ones show high antimicrobial activities, while other compounds show no activity against tested microorganisms.

2021·3citations·Mohamed A. Mohamed Teleb et al.·Polycyclic Aromatic Compounds

Polycyclic Aromatic Compounds